Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209‒249. https://doi.org/10.3322/caac.21660

Article  Google Scholar 

Cancer Genome Atlas Network 2012. Comprehensive molecular portraits of human breast tumours. Nature. 490 (7418), 61‒70. https://doi.org/10.1038/nature11412

Article  CAS  Google Scholar 

Cuzick J. 2017. Preventive therapy for cancer. Lancet Oncol. 18 (8), 472‒482. https://doi.org/10.1016/S1470-2045(17)30536-3

Article  Google Scholar 

Harbeck N., Gnant M. 2017. Breast cancer. Lancet. 389 (10074), 1134‒1150. https://doi.org/10.1016/S0140-6736(16)31891-8

Article  Google Scholar 

Rahman M.M., Brane A.C., Tollefsbol T.O. 2019. MicroRNAs and epigenetics strategies to reverse breast cancer. Cells. 8 (10), 1214. https://doi.org/10.3390/cells8101214

Article  CAS  Google Scholar 

Sharma S., Kelly T.K., Jones P.A. 2010. Epigenetics in cancer. Carcinogenesis. 31 (1), 27‒36. https://doi.org/10.1093/carcin/bgp220

Article  CAS  Google Scholar 

Rose M., Kloten V., Noetzel E., Gola L., Ehling J., Heide T., Meurer S.K., Gaiko-Shcherbak A., Sechi A.S., Huth S., Weiskirchen R., Klaas O., Antonopoulos W., Lin Q, Wagner W., Veeck J., Gremse F., Steitz J., Knüchel R., Dahl E. 2017. ITIH5 mediates epigenetic reprogramming of breast cancer cells. Mol. Cancer. 16 (1), 44. https://doi.org/10.1186/s12943-017-0610-2

Article  CAS  Google Scholar 

Jeong G.Y., Park M.K., Choi H.J., An H.W., Park Y.U., Choi H.J., Park J., Kim H.Y., Son T., Lee H., Min K.W., Oh Y.H., Lee J.Y., Kong G. 2021. NSD3-Induced methylation of H3K36 activates NOTCH signaling to drive breast tumor initiation and metastatic progression. Cancer Res. 81 (1), 77‒90. https://doi.org/10.1158/0008-5472.CAN-20-0360

Article  CAS  Google Scholar 

Klinge C.M. 2018. Non-coding RNAs: Long non-coding RNAs and microRNAs in endocrine-related cancers. Endocr. Relat. Cancer. 25 (4), 259‒282. https://doi.org/10.1530/ERC-17-0548

Article  Google Scholar 

Venkatesh J., Wasson M.D., Brown J.M., Fernando W., Marcato P. 2021. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack. Cancer Lett. 509, 81‒88. https://doi.org/10.1016/j.canlet.2021.04.002

Article  CAS  Google Scholar 

Fazal F.M., Chang H.Y. 2016. lncRNA structure: Message to the heart. Mol. Cell. 64 (1), 1‒2. https://doi.org/10.1016/j.molcel.2016.09.030

Article  CAS  Google Scholar 

Kim J., Piao H.L., Kim B.J., Yao F., Han Z., Wang Y., Xiao Z., Siverly A.N., Lawhon S.E., Ton B.N., Lee H., Zhou Z., Gan B., Nakagawa S., Ellis M.J., Liang H., Hung M.C., You M.J., Sun Y., Ma L. 2018. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat. Genet. 50 (12), 1705‒1715. https://doi.org/10.1038/s41588-018-0252-3

Article  CAS  Google Scholar 

Slack F.J., Chinnaiyan A.M. 2019. The role of non-coding RNAs in oncology. Cell. 179 (5), 1033‒1055. https://doi.org/10.1016/j.cell.2019.10.017

Article  CAS  Google Scholar 

Hazra A., Bose P., Sunita P., Pattanayak S.P. 2021. Molecular epigenetic dynamics in breast carcinogenesis. Arch. Pharm. Res. 44 (8), 741‒763. https://doi.org/10.1007/s12272-021-01348-0

Article  CAS  Google Scholar 

Wu H.J., Chu P.Y. 2021. Epigenetic regulation of breast cancer stem cells contributing to carcinogenesis and therapeutic implications. Int. J. Mol. Sci. 22 (15), 8113. https://doi.org/10.3390/ijms22158113

Article  CAS  Google Scholar 

Cheetham S.W., Gruhl F., Mattick J.S., Dinger M.E. 2013. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer. 108 (12), 2419‒2425. https://doi.org/10.1038/bjc.2013.233

Article  CAS  Google Scholar 

Huang J., Zhang S.Y., Gao Y.M., Liu Y.F., Liu Y.B., Zhao Z.G., Yang K. 2014. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: Potential biomarkers and therapeutic targets. Cell Prolif. 47 (4), 277‒286. https://doi.org/10.1111/cpr.12109

Article  CAS  Google Scholar 

Union for International Cancer Control (UICC) 2017. TNM Classification of Malignant Tumours. Eds Brierley J.D., Gospodarowicz M.K., Wittekind C. Oxford, UK: Wiley.

Google Scholar 

World Medical Association 2013. World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 310 (20), 2191‒2194. https://doi.org/10.1001/jama.2013.281053

Article  CAS  Google Scholar 

Loginov V.I., Pronina I.V., Filippova E.A., Burdennyy A.M., Lukina S.S., Kazubskaya T.P., Uroshlev L.A., Fridman M.V., Brovkina O.I., Apanovich N.V., Karpukhin A.V., Stilidi I.S., Kushlinskii N.E., Dmitriev A.A., Braga E.A. 2022. Aberrant methylation of 20 miRNA genes specifically involved in various steps of ovarian carcinoma spread: From primary tumors to peritoneal macroscopic metastases. Int. J. Mol. Sci. 23 (3), 1300. https://doi.org/10.3390/ijms23031300

Article  CAS  Google Scholar 

Hattermann K., Mehdorn H.M., Mentlein R., Schultka S., Held-Feindt J. 2008. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal. Biochem. 377 (1), 62‒71. https://doi.org/10.1016/j.ab.2008.03.014

Article  CAS  Google Scholar 

Selezneva A.D., Filippova E.A., Selezneva A.D., Lukina S.S., Pronina I.V., Ivanova N.A., Kazubskaya T.P., Burdennyy A.M., Braga E.A., Loginov V.I. 2022. Hypermethylation of long non-coding RNA genes group in the breast cancer development and progression. Bull. Exp. Biol. Med. 173 (6), 765‒769. https://doi.org/10.1007/s10517-022-05627-8

Article  CAS  Google Scholar 

Vrba L., Futscher B.W. 2017. Epigenetic silencing of MORT is an early event in cancer and is associated with luminal, receptor positive breast tumor subtypes. J. Breast Cancer. 20 (2), 198‒202. https://doi.org/10.4048/jbc.2017.20.2.198

Article  Google Scholar 

Di Fiore R., Suleiman S., Drago-Ferrante R., Felix A., OꞌToole S.A., O’Leary J.J., Ward M.P., Beirne J., Yordanov A., Vasileva-Slaveva M., Subbannayya Y., Pentimalli F., Giordano A., Calleja-Agius J. 2021. LncRNA MORT (ZNF667-AS1) in cancer—is there a possible role in gynecological malignancies? Int. J. Mol. Sci. 22 (15), 7829. https://doi.org/10.3390/ijms22157829

Article  CAS  Google Scholar 

Li H., Wang P., Liu J., Liu W., Wu X., Ding J., Kang J., Li J., Lu J., Pan G. 2020. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells. J. Clin. Lab. Anal. 34 (9), e23369. https://doi.org/10.1002/jcla.23369

Article  CAS  Google Scholar 

Burdennyy A.M., Filippova E.A., Ivanova N.A., Lukina S.S., Pronina I.V., Loginov V.I., Fridman M.V., Kazubskaya T.P., Utkin D.O., Braga E.A., Kushlinskii N.E. 2021. Hypermethylation of genes in new long noncoding RNA in ovarian tumors and metastases: A dual effect. Bull. Exp. Biol. Med. 171 (3), 370–374. https://doi.org/10.1007/s10517-021-05230-3

Article  CAS  Google Scholar 

Hu J., Huang H., Xi Z., Ma S., Ming J., Dong F., Guo H., Zhang H., Zhao E., Yao G., Yang L., Zhang F., Zheng W., Chen H., Huang T., Li L. 2022. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis. Cell Death Dis. 13 (9), 800. https://doi.org/10.1038/s41419-022-05189-7

Article  CAS  Google Scholar 

Yu C., Chen W., Cai Y., Du M., Zong D., Qian L., Jiang X., Zhu H. 2022. The lncRNA ZNF667-AS1 inhibits propagation, invasion, and angiogenesis of gastric cancer by silencing the expression of N-cadherin and VEGFA. J. Oncol. 2022–3579547. https://doi.org/10.1155/2022/3579547

Yang X., Wang C.C., Lee W.Y.W., Trovik J., Chung T.K.H, Kwong J. 2018. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. Cancer Lett. 28 (413), 23–34. https://doi.org/10.1016/j.canlet.2017.10.028

Article  CAS  Google Scholar 

Gokulnath P., de Cristofaro T., Manipur I., Di Palma T., Soriano A.A., Guarracino M.R., Zannini M. 2020. Long non-coding RNA HAND2-AS1 acts as a tumor suppressor in high-grade serous ovarian carcinoma. Int. J. Mol. Sci. 21 (11), 4059. https://doi.org/10.3390/ijms21114059

Article  CAS  Google Scholar 

Zhang H., Zhang Z., Wang D. 2019. Epigenetic regulation of lncRNA KCNKI5-ASI in gastric cancer. Cancer Manage. Res. 11, 8589–8602. https://doi.org/10.2147/CMAR.S186002

Article  CAS  Google Scholar 

Wang J., Yang C., Cao H., Yang J., Meng W., Yu M., Yu L., Wang B. 2023. Hypermethylation-mediated lncRNA MAGI2-as3 downregulation facilitates malignant progression of laryngeal squamous cell carcinoma via interacting with SPT6. Cell Transplant. 32 (9636897231154574). https://doi.org/10.1177/09636897231154574

Kim-Wanner S.Z., Assenov Y., Nair M.B., Weichenhan D., Benner A., Becker N., Landwehr K., Kuner R., Sültmann H., Esteller M., Koch I., Lindner M., Meister M., Thomas M., Bieg M., Klingmüller U., Schlesner M., Warth A., Brors B., Seifried E., Bönig H., Plass C., Risch A., Muley T. 2020. Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT: An exploratory study. J. Thorac. Oncol. 15 (8), 1338–1350. https://doi.org/10.1016/j.jtho.2020.03.023

Article  CAS  Google Scholar 

Al-Rugeebah A., Alanazi M., Parine N.R. 2019. MEG3: An oncogenic long non-coding RNA in different cancers. Pathol. Oncol. Res. 25 (3), 859–874. https://doi.org/10.1007/s12253-019-00614-3

Article  CAS  Google Scholar 

Zhang W., Shi S., Jiang J., Li X., Lu H., Ren F. 2017. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Biomed. Pharmacother. 91, 312–319. https://doi.org/10.1016/j.biopha.2017.04.085

Article  CAS  Google Scholar 

Zhang L., Liang X., Li Y. 2017. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway. Oncol. Rep. 38 (4), 2408–2416. https://doi.org/10.3892/or.2017.5871

Article  CAS  Google Scholar 

Chen X., Huang Y., Shi D., Nie C., Luo Y., Guo L., Zou Y., Xie C. 2020. LncRNA ZNF667-AS1 promotes ABLIM1 expression by adsorbing microRNA-1290 to suppress nasopharyngeal carcinoma cell progression. OncoTargets Ther. 20 (13), 4397–4409. https://doi.org/10.2147/OTT.S245554

Article  Google Scholar 

Zhuang L., Ding W., Ding W., Zhang Q., Xu X., Xi D. 2021. lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression. J. Cell. Physiol. 236 (3), 2178–2193. https://doi.org/10.1002/jcp.30004

Article  CAS  Google Scholar 

Yang Y., Yang H., Xu M., Zhang H., Sun M., Mu P., Dong T., Du S., Liu K. 2018. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway. Hum. Cell. 31 (3), 232–241. https://doi.org/10.1007/s13577-018-0206-1